BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Neuro-Hitech, Inc. 

One Penn Plaza
Suite 1503
New York  New York  10019  U.S.A.
Phone: 212-594-1215 Fax: 212-594-1242


SEARCH JOBS










 Company News
Neuro-Hitech, Inc. (NHPI) Announces Modification of Terms of Acquisition of MCR American Pharmaceuticals and AMBI Pharmaceuticals 11/20/2008 10:35:42 AM    More...
Neuro-Hitech, Inc. (NHPI) Announces Acquisition of MCR American Pharmaceuticals 6/11/2008 6:24:25 AM    More...
Neuro-Hitech, Inc. (NHPI) Receives Notice of Delisting from NASDAQ 3/31/2008 12:00:14 PM    More...
Neuro-Hitech, Inc. (NHPI) Receives Delisting Warning Letter from NASDAQ 3/21/2008 8:32:06 AM    More...
Neuro-Hitech, Inc. (NHPI) Announces Agreement with Numoda to Progress Development of Huperzine A in Alzheimer's Disease 3/10/2008 9:14:34 AM    More...
Neuro-Hitech, Inc. (NHPI) Receives Delisting Warning Letter from NASDAQ 2/25/2008 9:22:34 AM    More...
Neuro-Hitech, Inc. (NHPI) Reports Cognitive Improvement From Phase Two Clinical Trial of Huperzine A In Alzheimer's Disease Patients 2/1/2008 9:03:47 AM    More...
Neuro-Hitech, Inc. (NHPI) Announces Completion of Double-Blind Part of Phase Two Clinical Trial of Huperzine A in Alzheimer's Disease 12/14/2007 9:30:49 AM    More...
Neuro-Hitech, Inc. (NHPI) Announces Private Offering of $5.0 Million 11/30/2007 9:24:46 AM    More...
Neuro-Hitech, Inc. (NHPI) Director Terminates Rule 10b5-1 Plan 9/25/2007 1:08:06 PM    More...
123